Tag Archives: CYCC

Top 10 Medical Stocks To Own Right Now

Check out the companies making headlines before the bell:

BlackBerry – BlackBerry reported adjusted first-quarter profit of 3 cents per share, compared to analysts’ expectations of a breakeven quarter. The software and services company also saw revenue top estimates.

Medtronic – The medical device maker announced a 9 percent increase in its quarterly dividend to 50 cents per share.

United Rentals – The equipment rental company was upgraded to “buy” from “neutral” at UBS, which said cyclical and cost concerns surrounding the company are overdone.

JPMorgan Chase, Bank of America, Citigroup, Wells Fargo – These and other bank stocks are on watch today after 35 of the nation’s largest banks passed the Fed’s latest stress tests. The tests show that the banks have sufficient capital to weather severe adverse conditions.

Top 10 Medical Stocks To Own Right Now: EchoStar Corporation(SATS)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of CDAM (UK) Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CDAM+%28UK%29+Ltd

    These are the top 5 holdings of CDAM (UK) LtdAlphabet Inc (GOOGL) – 57,687 shares, 13.61% of the total portfolio. Shares added by 22.65%Open Text Corp (OTEX) – 1,703,053 shares, 12.52% of the total portfolio. Shares added by 57.24%EchoStar Corp (SATS) – 1,291,355 shares, 11.98% of the total portfolio. Shares added by 32.53%Athene Holding Ltd (ATH) – 1,339,253 shares, 11.64% of the total portfolio. Shares added by 22.45%Hilltop Holdings Inc (HTH) – 2,345,728

  • [By Max Byerly]

    Echostar Co. (NASDAQ:SATS) has received an average rating of “Hold” from the six research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $73.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Max Byerly]

    Teachers Advisors LLC grew its stake in shares of Echostar Co. (NASDAQ:SATS) by 9.2% in the fourth quarter, Holdings Channel reports. The fund owned 59,929 shares of the communications equipment provider’s stock after buying an additional 5,059 shares during the quarter. Teachers Advisors LLC’s holdings in Echostar were worth $3,590,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Echostar Holding Corp (NASDAQ:SATS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $51.33 and last traded at $52.44, with a volume of 104714 shares trading hands. The stock had previously closed at $51.79.

Top 10 Medical Stocks To Own Right Now: CRA InternationalInc.(CRAI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of CRA International (NASDAQ:CRAI) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday morning.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Navistar International Corporation (NYSE:NAV)Q2 2018 Earnings Conference CallJune 5, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lee Samaha]

    Shares of truck manufacturer PACCAR (NASDAQ:PCAR) rose 14.7% in January, according to data from S&P Global Market Intelligence. It was a strong month for the trucking sector overall, with Navistar (NYSE:NAV), Meritor (NYSE:MTOR), and Dana (NYSE:DAN) all rising more than 20%. The move in January represented another turn in the bear-and-bull debate that’s raged over the trucking sector in the past year.

  • [By Joseph Griffin]

    NavCoin (NAV) is a PoW/PoS coin that uses the X13 hashing algorithm. It launched on June 6th, 2014. NavCoin’s total supply is 62,938,003 coins. The Reddit community for NavCoin is /r/NavCoin and the currency’s Github account can be viewed here. NavCoin’s official Twitter account is @NavCoin. The official website for NavCoin is www.navcoin.org. The official message board for NavCoin is medium.com/nav-coin.

  • [By Shane Hupp]

    NavCoin (CURRENCY:NAV) traded up 17.9% against the dollar during the 1-day period ending at 15:00 PM E.T. on May 20th. Over the last week, NavCoin has traded up 19.5% against the dollar. One NavCoin coin can currently be bought for about $1.28 or 0.00015092 BTC on exchanges including Cryptopia, Binance, Bittrex and cfinex. NavCoin has a total market capitalization of $80.73 million and $13.02 million worth of NavCoin was traded on exchanges in the last day.

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

  • [By Rich Smith]

    Navistar (NYSE:NAV) stock had a tough time of things on Thursday. Posting its fifth-in-a-row earnings beat, Navistar nonetheless missed sales estimates slightly — and investors sold off its stock by 8.5%.

Top 10 Medical Stocks To Own Right Now: CDK Global, Inc.(CDK)

Advisors’ Opinion:

  • [By Max Byerly]

    CDK Global Inc (NASDAQ:CDK) shares hit a new 52-week low during trading on Wednesday after Morgan Stanley lowered their price target on the stock from $75.00 to $68.00. Morgan Stanley currently has an equal weight rating on the stock. CDK Global traded as low as $59.84 and last traded at $60.56, with a volume of 54440 shares changing hands. The stock had previously closed at $60.77.

  • [By Shane Hupp]

    Rikoon Group LLC lifted its stake in shares of CDK Global Inc (NASDAQ:CDK) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,873 shares of the software maker’s stock after purchasing an additional 1,102 shares during the quarter. Rikoon Group LLC’s holdings in CDK Global were worth $366,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CDK Global (CDK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    HMS (NASDAQ: CDK) and CDK Global (NASDAQ:CDK) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Max Byerly]

    CDK Global (NASDAQ:CDK) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Saturday.

  • [By Ethan Ryder]

    Silvercrest Asset Management Group LLC decreased its position in CDK Global Inc (NASDAQ:CDK) by 7.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,407 shares of the software maker’s stock after selling 1,079 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in CDK Global were worth $849,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own Right Now: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Nucor Co. (NYSE:NUE) have been given an average recommendation of “Buy” by the fourteen analysts that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $72.25.

  • [By Neha Chamaria]

    Founded in 1901, United States Steel (NYSE:X) is one of the oldest American companies. Yet, even with more than a century’s experience in steelmaking, U.S. Steel is hugely lagging Nucor (NYSE:NUE) in terms of sales. Nucor and Steel Dynamics (NASDAQ:STLD) have also consistently churned out greater profits from sales than U.S. Steel. While Nucor was founded in 1940, Steel Dynamics started operations only in 1993.

  • [By Jason Hall, Neha Chamaria, and Rich Duprey]

    Three that look particularly appealing today include Best Buy Co Inc (NYSE:BBY), Nucor Corporation (NYSE:NUE), and Starbucks Corporation (NASDAQ:SBUX). Not only do all three pay dividends yielding over 2%, but they also have solid long-term prospects that should lead to growing your capital investment in them in the years ahead. 

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

  • [By Stephan Byrd]

    Harel Insurance Investments & Financial Services Ltd. reduced its stake in shares of Nucor Co. (NYSE:NUE) by 31.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 2,200 shares of the basic materials company’s stock after selling 1,000 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Nucor were worth $138,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about Can-Fite Biopharma (NASDAQ:CANF) have trended positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6620747072303 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Max Byerly]

    CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce

Top 10 Medical Stocks To Own Right Now: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rubicon Technology (NASDAQ:RBCN) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

  • [By Shane Hupp]

    News coverage about Rubicon Technology (NASDAQ:RBCN) has been trending somewhat positive on Monday, according to Accern Sentiment. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rubicon Technology earned a coverage optimism score of 0.22 on Accern’s scale. Accern also assigned media stories about the semiconductor company an impact score of 43.6568126847622 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Medical Stocks To Own Right Now: Gorman-Rupp Company (GRC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. Its genesis date was November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. The official message board for GridCoin is cryptocurrencytalk.com/forum/464-gridcoin-grc. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. The official website for GridCoin is www.gridcoin.us. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here.

  • [By Max Byerly]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. It was first traded on November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. GridCoin’s official message board is cryptocurrencytalk.com/forum/464-gridcoin-grc. GridCoin’s official website is www.gridcoin.us.

  • [By Stephan Byrd]

    Gorman-Rupp Co (NYSE:GRC) Director Christopher H. Lake sold 2,000 shares of the firm’s stock in a transaction on Friday, August 17th. The stock was sold at an average price of $36.69, for a total value of $73,380.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Top 10 Medical Stocks To Own Right Now: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Max Byerly]

    Envestnet Asset Management Inc. lifted its stake in shares of Huntington Bancshares (NASDAQ:HBAN) by 33.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 196,941 shares of the bank’s stock after buying an additional 49,653 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Huntington Bancshares were worth $2,972,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Public Employees Retirement Association of Colorado lessened its stake in shares of Huntington Bancshares (NASDAQ:HBAN) by 4.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 197,768 shares of the bank’s stock after selling 10,068 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Huntington Bancshares were worth $2,986,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get Huntington Bancshares alerts:

    Active Mover: Huntington Bancshares Incorporated (NASDAQ: HBAN) (alphabetastock.com) P/E Ratio under Consideration – Huntington Bancshares Incorporated (NASDAQ: HBAN) (stocksmarketcap.com) Stocks You Can’t Afford to Pass Up: Huntington Bancshares Incorporated (NASDAQ:HBAN), Under Armour, Inc. (NYSE … (journalfinance.net) Is this stock is Oversold? Huntington Bancshares Incorporated (HBAN) (stockquote.review) Huntington Bancshares Incorporated (NasdaqGS:HBAN) & Eldorado Resorts, Inc. (NasdaqGS:ERI) Valuation at a Glance (parkcitycaller.com)

    Several equities research analysts have issued reports on the company. BidaskClub lowered Huntington Bancshares from a “buy” rating to a “hold” rating in a research note on Wednesday. JPMorgan Chase lifted their price objective on Huntington Bancshares from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Zacks Investment Research downgraded Huntington Bancshares from a “buy” rating to a “hold” rating in a report on Thursday, April 5th. BMO Capital Markets reiterated a “hold” rating and issued a $18.00 price objective on shares of Huntington Bancshares in a report on Wednesday, January 24th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $16.75 price objective on shares of Huntington Bancshares in a report on Wednesday, January 24th. Ten investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $16.98.

  • [By Lee Jackson]

    This smaller cap bank could be an outstanding addition for more aggressive portfolios. Huntington Bancshares Inc. (NASDAQ: HBAN) operates as a holding company for the Huntington National Bank, which provides commercial, small business, consumer and mortgage banking services. Its Retail and Business Banking segment offers financial products and services, including checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans and small business loans, as well as investments, insurance, interest rate risk protection and foreign exchange and treasury management services.

Top 10 Performing Stocks To Watch For 2019

Interest rates are surging and stocks like J.P. Morgan Chase and Goldman Sachs would make great additions to a portfolio in times like these, if history is any indication.

Shares of J.P. Morgan surge an average of 5.2 percent over a one-month span when rates are rising sharply, while Goldman’s stock averages a gain of 3.9 percent in such instances. Banks usually benefit from higher rates as they make loans more profitable.

DowDuPont, Exxon Mobil and Visa are also among the best-performing stocks in this environment. When rates move sharply higher, DowDuPont and Exxon Mobil both average gains of 3.5 percent, while Visa posts averages a rise of 3.4 percent.

CNBC used analytics tool Kensho to determine the best-performing stocks in the Dow Jones Industrial Average when the 10-year Treasury note yield rises 25 basis points or more over a span of 30 days. There have been 18 instances of such a move happening since 2008. Last week alone, the 10-year yield rose more than 15 basis points.

Top 10 Performing Stocks To Watch For 2019: Portland General Electric Company(POR)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine upgraded shares of Portland General Electric (NYSE:POR) from a sell rating to a hold rating in a report issued on Friday.

    Several other equities research analysts also recently commented on POR. Guggenheim reiterated a hold rating and set a $40.00 target price on shares of Portland General Electric in a research report on Friday, February 23rd. Bank of America downgraded shares of Portland General Electric from a neutral rating to an underperform rating and cut their target price for the stock from $41.00 to $39.00 in a research report on Tuesday, March 6th. JPMorgan Chase & Co. cut their target price on shares of Portland General Electric from $42.00 to $41.00 and set a neutral rating on the stock in a research report on Tuesday, March 27th. Finally, Zacks Investment Research upgraded shares of Portland General Electric from a sell rating to a hold rating in a research report on Wednesday, May 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $42.44.

  • [By Shane Hupp]

    Sky Solar (NYSE: POR) and Portland General Electric (NYSE:POR) are both utilities companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.

  • [By Max Byerly]

    Opus Investment Management Inc. lowered its holdings in Portland General Electric (NYSE:POR) by 8.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 95,200 shares of the utilities provider’s stock after selling 8,400 shares during the quarter. Opus Investment Management Inc. owned about 0.11% of Portland General Electric worth $3,857,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Massachusetts Financial Services Co. MA grew its stake in shares of Portland General Electric (NYSE:POR) by 16.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 646,219 shares of the utilities provider’s stock after buying an additional 93,580 shares during the period. Massachusetts Financial Services Co. MA owned 0.72% of Portland General Electric worth $27,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Performing Stocks To Watch For 2019: Envestnet, Inc(ENV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Envestnet Inc (NYSE:ENV) insider Shelly O’brien sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, June 4th. The stock was sold at an average price of $54.23, for a total value of $216,920.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Stephan Byrd]

    Zillow (NASDAQ: ZG) and Envestnet (NYSE:ENV) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

  • [By Joseph Griffin]

    MoneyOnMobile (NYSE: ENV) and Envestnet (NYSE:ENV) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership.

  • [By Ethan Ryder]

    Total System Services (NYSE: ENV) and Envestnet (NYSE:ENV) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Envestnet (ENV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in shares of CRH Medical Corp (NYSEAMERICAN:CRHM) by 36.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 867,243 shares of the company’s stock after selling 495,404 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned about 1.19% of CRH Medical worth $3,564,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Watch For 2019: Integrated Electrical Services Inc.(IESC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Gendell Jeffrey L decreased its stake in shares of IES Holdings Inc (NASDAQ:IESC) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,319,064 shares of the technology company’s stock after selling 36,081 shares during the period. IES comprises 21.0% of Gendell Jeffrey L’s portfolio, making the stock its largest holding. Gendell Jeffrey L owned about 0.58% of IES worth $186,634,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Performing Stocks To Watch For 2019: Hollysys Automation Technologies Ltd.(HOLI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been given a consensus rating of “Hold” by the five brokerages that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $25.00.

  • [By Travis Hoium]

    Shares of Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) fell as much as 31.5% in trading Wednesday, after the company reported fiscal fourth-quarter 2018 results. By the time the market closed, some of those gains had been clawed back but were still down 11.1% for the day. 

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Stephan Byrd]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $21.44.

Top 10 Performing Stocks To Watch For 2019: Synchronoss Technologies Inc.(SNCR)

Advisors’ Opinion:

  • [By Timothy Green]

    Shares of Synchronoss Technologies (NASDAQ:SNCR) were suspended from trading on the Nasdaq on Monday due to the company’s failure to satisfy the Nasdaq listing requirements. Synchronoss hasn’t filed a quarterly or annual report with the SEC since February 2017 due to an ongoing financial restatement process. The stock will be quoted on the OTC markets under the same trading symbol during the suspension period. The stock dropped about 7% in pre-market trading.

  • [By Dan Caplinger]

    It’s been a hard road for Synchronoss Technologies (NASDAQ:SNCR). For more than a year, the company worked through restating financials dating back well into the past, and the company found itself having to list its shares on the bulletin boards after the Nasdaq suspended trading in the stock. Nevertheless, through all of its trials and tribulations, Synchronoss has remained steadfast in its determination to emerge from its difficulties stronger than ever. Announcing financial results was a key step toward getting things back to normal.

  • [By Steve Symington]

    Synchronoss Technologies (NASDAQ:SNCR) stock popped 21.6% on Friday after the cloud-based enterprise computing and messaging specialist announced its common shares have been approved for listing on the Nasdaq, which means they’ll resume trading on the widely followed index when the market opens on Monday, October 1, 2018.

  • [By Motley Fool Transcribing]

    Synchronoss Technologies (NASDAQ:SNCR) Q2 2018 Earnings Conference CallAug. 9, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Performing Stocks To Watch For 2019: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    SCS Group (LON:SCS)‘s stock had its “buy” rating reaffirmed by analysts at Peel Hunt in a research note issued to investors on Tuesday.

  • [By Ethan Ryder]

    Peel Hunt reissued their buy rating on shares of SCS Group (LON:SCS) in a research note published on Thursday.

    SCS Group stock opened at GBX 211 ($2.75) on Thursday. SCS Group has a one year low of GBX 127.13 ($1.66) and a one year high of GBX 237 ($3.09).

  • [By Max Byerly]

    SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.

  • [By Ethan Ryder]

    Seaport Global Securities upgraded shares of Steelcase (NYSE:SCS) from a neutral rating to a buy rating in a report published on Friday, Marketbeat Ratings reports. Seaport Global Securities currently has $20.00 price objective on the business services provider’s stock.

Top 10 Performing Stocks To Watch For 2019: SM Energy Company(SM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SM Energy Co (NYSE:SM) gapped up prior to trading on Tuesday . The stock had previously closed at $32.22, but opened at $32.20. SM Energy shares last traded at $31.49, with a volume of 60289 shares trading hands.

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY WARNING: “SM Energy Sees Unusually High Options Volume (SM)” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3353537/sm-energy-sees-unusually-high-options-volume-sm.html.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on SM Energy (SM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Shares of oil producers Laredo Petroleum (NYSE:LPI) and SM Energy (NYSE:SM), as well as units of Golar LNG Partners LP (NASDAQ:GMLP), an MLP that owns liquified natural gas carriers and floating storage and regasification units, all declined by double digits by Friday afternoon. Lower oil prices weighed on the first two, while an analyst downgrade was the culprit in the latter.

  • [By Logan Wallace]

    Scotia Howard Weill upgraded shares of SM Energy (NYSE:SM) from a sector perform rating to a sector outperform rating in a research note published on Thursday morning.

  • [By Joseph Griffin]

    SM Energy (NYSE:SM) had its target price lifted by Citigroup to $29.00 in a report issued on Friday morning, The Fly reports. The brokerage currently has a neutral rating on the energy company’s stock.

Top 10 Performing Stocks To Watch For 2019: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Ethan Ryder]

    Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Coherent (COHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. boosted its position in Coherent, Inc. (NASDAQ:COHR) by 6.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 635,597 shares of the scientific and technical instruments company’s stock after purchasing an additional 41,113 shares during the quarter. Epoch Investment Partners Inc. owned approximately 2.62% of Coherent worth $99,420,000 at the end of the most recent quarter.

  • [By Keith Noonan]

    Coherent, Inc. (NASDAQ:COHR) stock jumped 20.6% in August, according to data provided by S&P Global Market Intelligence. The company published third-quarter results at the end of July that came in below the market’s expectations, but comments during the company’s earnings call appear to have helped the stock regain some ground.

  • [By Logan Wallace]

    Coherent (NASDAQ: COHR) and Integra Lifesciences (NASDAQ:IART) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

  • [By ]

    Coherent, Inc. (NASDAQ:COHR) is one of the oldest companies in the laser technology space based in California, US. The company employs around 5,218 employees and has grown rapidly in terms of revenues as well as profits over the past few years. A recent sell-off as a result of forex risks and a negative market sentiment with respect to lasers has brought the stock price down to reasonable valuations. However, analysts continue to remain bullish on the stock with target prices showing a minimum appreciation of 40% over the current market price.

Top 5 Value Stocks To Own For 2018

OncoMed Pharmaceuticals (OMED) has lost more than a third of its value Monday, after Bayer decided not to exercise its option to license the firms Phase II-ready WNT pathway inhibitors Vantictumab and Ipafricept, which treat pancreatic cancer.

Pixabay

That wasnt the only bad news, however, as the firms randomized-controlled Phase II “YOSEMITE” trial of pancreatic cancer drug demcizumab also missed its primary endpoint.

Leerinks Michael Schmidt and his team reiterated a Market Perform rating on the stock Monday, and lowered their price target from $10 to $6 on the news, calling it a “double setback” for OncoMed.

More detail from the note:

This is a major setback for OMED and in our view for the cancer stem cell targets more broadly, which have been a difficult area of drug development. We’ve been cautious on the probability-of-success of these agents and see more promise on OMED’s recent efforts in building a second area of focus in immuno-oncology. Going forward, OMED plans to review and prioritize its R&D pipeline after results from the still pending tarextumab Phase II “PINNACLE” trial in small cell lung cancer (SCLC) and data from the demcizumab “DENALI” trial in NSCLC are available in 2Q17. We remain MP rated in light of the uncertainties around OMED’s pipeline and strategy at this point. We previously assigned a 30% probability of success (POS) to demcizumab which we now have removed from our model. We also think chances that CELG will opt-into this program are slim and we have removed associated POS-adjusted milestone payments from our model. OMED has cash to run operations through 3Q18.

Top 5 Value Stocks To Own For 2018: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Paul Ausick]

    ArQule Inc. (NASDAQ: ARQL) dropped about 23% Friday, to post a new 52-week low of $1.13 after closing at $1.47 on Thursday. The stock’s 52-week high is $2.17. Volume was about 15 times the daily average of around 150,000 shares. The biopharmaceutical company said this morning that a phase 3 trial of a cancer drug did not meet the primary endpoint of improving overall survival.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Value Stocks To Own For 2018: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Top 5 Value Stocks To Own For 2018: Live Nation Entertainment, Inc.(LYV)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise(NASDAQ:AAXN), Grupo Aeroportuario del Pacific(NYSE:PAC), ResMed(NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation(NYSE:LYV).

  • [By Anders Bylund]

    World-leading event organizer and ticker seller Live Nation Entertainment Inc. (NYSE:LYV) reported first-quarter results on Thursday. The company posted 19% top-line growth and 76% higher cash flows, and management is leaning on rock festivals and amphitheater shows to fuel further growth.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer checked in with Michael Rapino, president and CEO of Live Nation Entertainment (LYV) , a stock that’s up 44% since Cramer last spoke with him a little more than a year ago but also one that fell 3% in today’s session on what appeared to be solid quarterly results.

  • [By Motley Fool Staff]

    Stock No. 5: That leads us to our “L” stock, and L is Live Nation (NYSE:LYV). This is the company that was formed by a merger of Live Nation, the concert venue and rock-star-promoting business that it is. So many musicians, today, of course, make most of their money on tours, since the sale of CDs, you might have noticed, has dropped off a cliff in recent years. Live Nation, then, bought a merger with Ticketmaster, so this is the company that sells you the tickets to come into its venues to watch the entertainment that it’s promoting. It’s a tremendously powerful model.

  • [By Anders Bylund]

    Shares of Live Nation Entertainment (NYSE:LYV) closed 12.5% higher on Friday, following the release of strong first-quarter results. Earlier in the day, share prices jumped as much as 14.9% higher.

Top 5 Value Stocks To Own For 2018: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By ]

    The markets saw red on Thursday, as shares of Action Alerts PLUS holdings Apple (AAPL)   and Nvidia (NVDA) , Taiwan Semiconductor (TSM) , Micron (MU) and many others all declined. The interest rate watch is on, as are concerns that inflation could gain steam sooner than expected.

  • [By Ethan Ryder]

    Massachusetts Financial Services Co. MA lowered its stake in Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:TSM) by 5.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 55,308,319 shares of the semiconductor company’s stock after selling 3,214,724 shares during the quarter. Taiwan Semiconductor Mfg. comprises approximately 1.0% of Massachusetts Financial Services Co. MA’s investment portfolio, making the stock its 20th biggest holding. Massachusetts Financial Services Co. MA’s holdings in Taiwan Semiconductor Mfg. were worth $2,420,292,000 as of its most recent SEC filing.

  • [By ]

    Judging by the speculation and the news flowing out of the chip space, Action Alerts PLUS holding Apple (AAPL) may have to wait a bit before breaking through the $1 trillion market cap level. The commentary out of chip supplier Taiwan Semiconductor (TSM) , a company that counts Apple, Qualcomm (QCOM) and Nvidia (NVDA) as customers, that current quarter sales will be about $1 billion less than analysts’ estimates pressured most of the tech space.

  • [By Ashraf Eassa]

    For years now, chip giantIntel(NASDAQ:INTC) has talked about how it hopes to compete in the contract chip manufacturing market dominated byTaiwan Semiconductor Manufacturing Company(NYSE:TSM) andSamsung(NASDAQOTH:SSNLF).

Top 5 Value Stocks To Own For 2018: Oak Valley Bancorp (CA)(OVLY)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

Top 10 High Tech Stocks To Watch For 2018

Bond yields at four-year highs are seen as a positive signal of a strengthening economy. But investors have taken it as a negative signal for stocks.

These moves are causing an identity crisis for equity markets, says Scott Redler, chief strategic officer at T3Live.com.

“It’s a good sign for the economy, but if you recall, the bull market is about 9 years old. For about five, six years of that bull market, they were buying bad news because the markets loved accommodation,” Redler told CNBC’s “Futures Now” on Tuesday.

“We don’t have much of that anymore, so now it’s time for the market to stand on its own two feet,” he added. “At this point, they’re actually selling the good news, which you don’t want to see.”

Since the financial crisis, stock markets have generally acted negatively to any hint of tightening monetary policy from the Federal Reserve. The current bull market began in March 2009, less than six months after the central bank cut interest rates to near zero.

Top 10 High Tech Stocks To Watch For 2018: Capella Education Company(CPLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Capella Education Company (NASDAQ: CPLA) got a boost, shooting up 32 percent to $86.60. Strayer Education Inc (NASDAQ: STRA) and Capella Education agreed to an all-stock merger. Capella Education also posted upbeat quarterly earnings.

Top 10 High Tech Stocks To Watch For 2018: Microsoft Corporation(MSFT)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    According to Digi-Capital, the augmented reality market will account for about $90 billion in revenue by 2020. Microsoft’s ARHoloLens can be a big part of its AR strategy to avoid being left behind in this space. Microsoft hassubmittedHoloLens for governmental approval in Chinaand added the manufacturer ‘3Glasses’ to its list of headset developers that already includes Acer, ASUS, Dell, HP and Lenovo. Microsoft’s HoloLens mixed reality headset has already been launched in Europe, Australia, New Zealand.In the U.K. the HoloLens costs 拢2,719, while in the U.S., it’s priced at $3,000. (See Also:MSFT Stock: Should You Buy Microsoft Corporation (MSFT) Stock Going Into 2017?)

  • [By Danny Vena]

    Microsoft’s (NASDAQ:MSFT) Cortana is available across its Windows 10-based devices including phones, tablets and PC’s. It has many competing features, but has exhibited difficulties responding to requests, reminiscent of Siri’s early days. Microsoft announced late last year that it would open Cortana to third party integration, so expect a number of hardware integrations on the horizon. It has yet to introduce an interactive speaker, but its first hardware partner is Harman Kardon and one is expected sometime this year. In a shrewd move, the kit used by developers is remarkably similar to that of Alexa, allowing them to piggyback off the work they have already done. This will accelerate the process of producing hardware that will integrate Cortana.

  • [By Douglas A. McIntyre]

    Apple Inc. (NASDAQ: AAPL) is the most valuable company in America based on market cap and is unlikely to let go of that position in the foreseeable future. However, the race for second place has tightened as Microsoft Corp. (NASDAQ: MSFT) has caught up with Amazon.com Inc. (NASDAQ: AMZN).

Top 10 High Tech Stocks To Watch For 2018: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Encana Corp. (NYSE: ECA) is rated Buy with an unchanged price target of $16. The EPS estimate for 2017 was lowered from $0.42 to $0.34, and the 2018 estimate was also lowered, from $1.47 to $1.28. The shares ended the weekat $11.44, in a 52-week range of $4.90 to $13.85. The consensus 12-month price target is $14.95.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Vodafone Group (VOD) , Schlumberger (SLB) , Encana (ECA) , Arconic (ARNC) and AdvanSix (ASIX) .

    Cramer was bearish on U.S. Silica Holdings (SLCA) .

  • [By Money Morning News Team]

    Canada-based Encana Corp. (NYSE: ECA) was the eighth top oil company stock in 2016, with a 131% gain over the year. ECA and its subsidiaries focus on developing, exploring, producing, and marketing natural gas, liquefied natural gas, and oil in North America.

Top 10 High Tech Stocks To Watch For 2018: Honeywell International Inc.(HON)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Laurie Kulikowski]

    HON is our top pick and a core EE/MI holding. While fundamentals are not best-in-class, we see HON as the best Energy play within the group with overall profit growth continuing to stand out next year, driven by high business quality and ongoing execution around cost and margins. And with ’17 the "inflection" year for revenues and Elster accretion, coupled with plenty of balance sheet optionality, we believe the stock deserves to trade at a premium versus an average discount across a range of metrics, including an adjustment for pension. 

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

Top 10 High Tech Stocks To Watch For 2018: World Energy Solutions Inc(DE)

Advisors’ Opinion:

  • [By JJ Kinahan]

    Earnings season is starting to slow down a little bit, although there are still many major companies left to report. Over the next few weeks, NVIDIA Corporation (NASDAQ: NVDA), Home Depot Inc. (NYSE: HD), Lowe’s Companies, Inc. (NYSE: LOW), Walmart Inc. (NYSE: WMT), Target Corporation (NYSE: TGT) and Deere & Company (NYSE: DE) are just some of the bigger names scheduled to release quarterly results.

  • [By Paul Ausick]

    But much of that response may simply have been reflexive the so-called knee-jerk reaction to anything that threatens to raise prices. Companies that consume a lot of steel, like Caterpillar Inc. (NYSE: CAT) and Deere & Co. (NYSE: DE), have not commented yet.

  • [By Chris Lange]

    Deere & Co. (NYSE: DE) is scheduled to release its most recent quarterly results Friday. The consensus forecast calls for $1.19 in EPS and $6.42 billion in revenue. Shares ended the week at $154.93. The consensus price target is $171.15, and the 52-week range is $106.72 to $171.96.

Top 10 High Tech Stocks To Watch For 2018: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Top 10 High Tech Stocks To Watch For 2018: NextEra Energy Partners, LP(NEP)

Advisors’ Opinion:

  • [By Travis Hoium]

    Leading the charge are two yieldcos — NextEra Energy Partners (NYSE:NEP) and 8point3 Energy Partners (NASDAQ:CAFD) — and utility company AES Corporation (NYSE:AES). Here’s a look at why they’re good dividend stocks to own today.

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

  • [By Lisa Levin]

    Wednesday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from TransAlta Corporation (NYSE: TAC) and NextEra Energy Partners, LP (NYSE: NEP).

  • [By Matthew DiLallo]

    NextEra Energy Partners (NYSE:NEP) operates and manages energy assets that have a cleaner profile, such as natural gas pipelines and wind and solar power-generating facilities. The other common denominator is that the company secured long-term contracts for the power these assets produce as well as the capacity of its pipelines, which provides it with relatively steady cash flow. That gives it money with which to pay a lucrative distribution that currently yields 4%.

Top 10 High Tech Stocks To Watch For 2018: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Daniel Sparks]

    Shares of rental car company Hertz (NYSE:HTZ) fell as much as 11.7% on Thursday after analysts at Morgan Stanley cut its price target for the stock from $15 to $12. Shares closed the trading day down about 11.4%.

  • [By Lisa Levin]

    Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.

    Commodities

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Hertz Global Holdings (HTZ) , General Motors (GM) , Pandora Media (P) , Cedar Fair (FUN) , Quotient Technology (QUOT) and Rite Aid (RAD) .

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

Top 10 High Tech Stocks To Watch For 2018: Tower International, Inc.(TOWR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tower International (NYSE:TOWR) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Wednesday.

Top 10 High Tech Stocks To Watch For 2018: Volkswagen Aktiengesellschaft (VLKAY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Welcome to the December 2016 edition of EV company news. There has been plenty of exciting EV market news including Volkswagen’s (OTCPK:VLKAY) plan to have a 373 mile (597 km) range EV by 2020. November delivered the second best ever EV sales month globally. Chinese cars filled the top 3 best sellers.

  • [By ]

    The ‘Jolt’ investing tip of the day actually goes out to C-suite executives across the word: Always watch your back because someone is always vying for the top gig. Reading the various Volkswagen (VLKAY) CEO shake-up news, it’s pretty clear new CEO Herbert Diess undermined his now former boss Matthias M眉ller. He reportedly built up a base of support among board members and shareholders to appoint him as CEO, despite M眉ller’s success turning around VW after the emissions scandal. Crazy, but hey it’s vicious out there.  

  • [By ]

    Volkswagen AG (VLKAY) led the Dax higher, gaining 1.02% to 178.82, after the German carmaker reshuffled its top management, naming former BMW AG (BMWYY) executive Herbert Diess as CEO, replacing Matthias Mueller, in the company’s biggest management change since the diesel emissions scandal in 2015.

  • [By ]

    That’s good news for the industry as a whole — ranging from Tesla to General Motors Co.  (GM) , Ford Motor Co.  (F) , Volkswagen (VLKAY) and others.

  • [By ]

    Volkswagen AG (VLKAY) shares were also on the back foot, falling 2.4% in Frankfurt and holding down gains for the DAX performance index after news late Thursday that former CEO Martin Winterkorn had been charged with conspiracy by the U.S. Department of Justice for his role in the firm’s diesel-gate scandal.  

best securities to invest in

The Mexican peso is headed for its largest monthly gain in nearly five years as President Donald Trump and his partisans suffer the first major legislative setback of his presidency.

This looming milestone represents drastic and, many believed, improbable, turnaround for the peso, the most heavily traded currency in Latin America: Two months ago, just as Trump was preparing to take the oath of office, the currency plunged to an all-time low. It has risen nearly 10% against the dollar since then, and since the beginning of March, the greenback has slid nearly 7% against the peso.

best securities to invest in: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

best securities to invest in: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

best securities to invest in: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

best securities to invest in: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Both Evenity and Tymlos are anabolic treatments, which means they encourage bone growth, rather than merely preventing bones from becoming more brittle, as prior generation osteoporosis drugs have done. While Eli Lilly (NYSE:LLY) was the first to market a drug in this class when Forteo gained marketing approval in 2002, it has faced no competitors despite achieving $1.5 billion in global sales last year, including $770 million in the United States. All of its patents expire by August 2019.

  • [By Keith Speights]

    With this rapidly growing market, there are plenty of opportunities for investors. Zoetis (NYSE:ZTS), Merck (NYSE:MRK), and Eli Lilly (NYSE:LLY) stand out as the top animal-health companies to buy in 2017. Here’s why.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

  • [By Johanna Bennett]

    Eli Lilly & Co. (LLY) and Biogen (BIIB) are far from the only two drug makers racing to deliver a new treatment for Alzheimers disease. But they are pretty much leading the pack.

    The market for an effective therapy that actually slows the progression of the disease would likely generate billions of dollars in annual sales. It is quite literally the drug industrys version of the holy grail.

    And according to Barclays analysts Geoff Meacham and Paul Choi, the next few weeks could prove to be one of the most fertile periods in Alzheimers disease research since 2008.

    We think the most likely outcome for Lilly’s Phase 3 EXPEDITION 3 (E3) solanezumab trial is the primary cognition (ADAS-Cog14) endpoint is met (just achieving statistical significance with a p-value <0.05) and mixed results on the secondary endpoints including function (ADL), which we believe should be good enough to support a regulatory submission. While aducanumab has a marginally different mechanism of action, we nevertheless expect BIIB shares to trade in sympathy to Lilly.

    Implications for Biogen and Merck: The E3 results are likely to result in volatility for Biogen (up 20-30%, down 10-15%) as Alzheimer’s drives both long-term growth and M&A value even though aducanumab works differently from solanezumab.

    Aducanumab dose titration data is expected at the CTAD meeting (San Diego, Dec. 9). Merck’s Phase 2/3 EPOCH verubecestat (BACE) trial is scheduled to finish in June 2017 but unlike E3, PET scans/CSF tests for A were not an inclusion criteria. We think Merck shares could move 3% to 5% in either direction in sympathy to E3.

    At $76.58, Lillys share price has fallen more than 9% over the past year, while Biogen has climbed more than 9% over the same span.

best securities to invest in: Superior Drilling Products, Inc.(SDPI)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Superior Drilling Products Inc.(NYSE: SDPI) is based in Utah and manufactures equipment used in drilling for the natural gas and oil mining sectors.